Study of CD160 expression in B-chronic Lymphocytic Leukemia

A Mohammed, MM Azab - Zagazig University Medical Journal, 2022 - journals.ekb.eg
B-cell lymphoproliferative disorders (B-CLPD) are a biologically heterogeneous group of
malignant diseases characterized by accumulation of mature B lymphocytes in the bone …
相关文章

Study of CD160 expression in B-chronic Lymphocytic Leukemia

A Mohammed, MM Azab - Zagazig University Medical Journal, 2022 - journals.ekb.eg
B-cell lymphoproliferative disorders (B-CLPD) are a biologically heterogeneous group of
malignant diseases characterized by accumulation of mature B lymphocytes in the bone …

Study of CD160 expression in B-chronic Lymphocytic Leukemia.

A Mohammed, MM Azab, GM El-akad… - Zagazig University …, 2022 - search.ebscohost.com
Background: B-cell lymphoproliferative disorders (B-CLPD) are a biologically
heterogeneous group of malignant diseases characterized by accumulation of mature B …

Study of CD160 expression in B-chronic Lymphocytic Leukemia

A Mohammed, MM Azab, GM El-akad… - Zagazig University …, 2022 - zumj.journals.ekb.eg
B-cell lymphoproliferative disorders (B-CLPD) are a biologically heterogeneous group of
malignant diseases characterized by accumulation of mature B lymphocytes in the bone …